[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-508403-105":59,"doc-detail-508403-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cost-evaluation-of-current-pulmonary-mtb-diagnosis-process-in-a-hospital-in-abu-dhabi-proposal-to-implement-the-world-health-organization-mtb-clinical-pathway","Cost Evaluation of Current Pulmonary MTB Diagnosis Process in a Hospital in Abu Dhabi - Proposal to Implement the World Health Organization MTB Clinical Pathway","","Assessing pulmonary Mycobacterium tuberculosis (MTB) diagnosis pathways in Abu Dhabi, the study estimates average costs and length of stay for suspected patients admitted from the emergency department to respiratory isolation rooms using a classic approach (3 AFB smears plus MTB cultures). It compares current admission practice with implementing the World Health Organization (WHO) X-pert MTB/RIF outpatient clinical pathway. A retrospective audit quantified true accrued costs and modeled WHO pathway costs for the same cohort, informing potential savings and resource implications.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cost-evaluation-of-current-pulmonary-mtb-diagnosis-process-in-a-hospital-in-abu-dhabi-proposal-to-implement-the-world-health-organization-mtb-clinical-pathway/508403/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cost-evaluation-of-current-pulmonary-mtb-diagnosis-process-in-a-hospital-in-abu-dhabi-proposal-to-implement-the-world-health-organization-mtb-clinical-pathway/508403.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-10-05",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What diagnostic pathways does the study compare for suspected pulmonary MTB in Abu Dhabi?","Question",{"text":113,"@type":114},"It compares the current hospital process using 3 AFB smears and MTB cultures for inpatient evaluation versus implementing the WHO X-pert MTB/RIF outpatient clinical pathway.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the study performed and what data were reported?",{"text":118,"@type":114},"A quality improvement project used a retrospective audit and data analysis of suspected pulmonary MTB admissions, reporting true accrued costs for current practice and estimated costs using the WHO pathway.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the main findings regarding cost and admissions?",{"text":122,"@type":114},"Cost analysis showed that 62% of diagnostic work-up costs were accumulated during admissions that ultimately proved MTB negative, and the WHO X-pert MTB/RIF pathway was estimated to cost about one-tenth as much as the current practice.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},508403,1791409462,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Original Article Eurasian J Emerg Med. 2023;22(2): 93-8  \nCost Evaluation of Current Pulmonary MTB Diagnosis Process in a Hospital in Abu Dhabi and Proposal to Implement the World Health Organization MTB Clinical Pathway  \n Ward Ghaleb1,  Yamama Aljishi2,  Sanjay Ayathan3,  Ayesha Almemari3  \n1 New Medical Centre, Emergency Medicine Department, Abu Dhabi, UAE  \n2 King Fahad Specialist Hospital, Department of Infectious Diseases, Dammam, Kingdome of Saudi Arabia  \n3 Shaikh Shakbout Medical City, Department of Emergency Medicine, Abu Dhabi, UAE  \nAbstract  \nAim: Mycobacterium tuberculosis (MTB) is a leading cause of death worldwide. The World Health Organization (WHO) recommends X-pert MTB/RIF or X-pert Ultra as the initial test for pulmonary MTB diagnosis. While several studies have explored the cost-effectiveness of this technology, none have specifically looked at its use in the United Arab Emirates (UAE) . To evaluate the average estimated cost and length of stay for suspected MTB patients admitted from the emergency department to the respiratory isolation rooms to rule out MTB using the MTB classic diagnosis pathway of 3 AFB smear and MTB cultures compared to the estimated cost if the WHO X-pert MTB/RIF outpatient pathway is implemented for suspected MTB.  \nMaterials and Methods: A quality improvement project was conducted with a retrospective audit and data analysis of suspected pulmonary MTB infection at a secondary care hospital in Abu Dhabi, UAE. We report the true accrued costs of the current admission practice for management of suspected pulmonary MTB. We also report the estimated cost of working up these same patients with the WHO pathway using X-pert MTB/RIF testing.  \nResults: Data analysis demonstrated that 62% of the cost of working up suspected pulmonary MTB was accumulated during admissions for patients who ultimately proved to be MTB negative. Cost evaluation of study data suggests that using the WHO X-pert MTB/RIF clinical pathway would cost approximately one-tenth as much as the current practice.  \nConclusion: This analysis presents evidence for cost savings associated with the use of the WHO X-pert MTB/RIF clinical pathway in a low MTB incidence area such as the UAE. Further analysis to assess how the pulmonary MTB diagnostic pathway was influenced by COVID-19 is needed. Keywords: Pulmonary MTB, emergency department, cost evaluation, mycobacterium tuberculosis, WHO clinical pathway, X-pert MTB/RIF, AFB smear  \nCorresponding Author: Ayesha Almemari MD, Shaikh Shakbout Medical City, Department of Emergency Medicine, Abu Dhabi, UAE  \nPhone: +971506920923 E-mail: amemari@ssmc.ae ORCID ID: [orcid.org/0000-0002-2546-5117](orcid.org/0000-0002-2546-5117)  \nCite this article as: Ghaleb W, Aljishi Y, Ayathan S, Almemari A. Cost Evaluation of Current Pulmonary MTB Diagnosis Process in a Hospital in Abu Dhabi and Proposal to Implement the World Health Organization MTB Clinical Pathway. Eurasian J Emerg Med. 2023;22(2): 93-8.  \nReceived: 22.04.2022  \nAccepted: 25.01.2023  \n©Copyright 2023 The Emergency Physicians Association of Turkey / Eurasian Journal of Emergency Medicine published by Galenos Publishing House. Licenced by Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) 4.0 International License.  \nIntroduction  \nMycobacterium tuberculosis (MTB) is an infectious disease commonly affecting the lungs (pulmonary MTB), also it may involve other organs (1) . Prompt diagnosis of active pulmonary MTB is a priority for TB control, both for treating the individual and for public health intervention to reduce further spread in the community (2) . MTB is often a curable disease if it is detected early and effectively treated (3) . In 2018, the United Arab Emirates (UAE) total population was 10 million. The World Health Organization (WHO) estimated UAE MTB incidence at 1 (0 .88-1.2) per 100 000 signifying that UAE is a low MTB incidence and burden country (4) .  \nCurrent practice in many hospitals in UAE in","cbCaisKNaoY0w1vr","https://ap.wps.com/l/cbCaisKNaoY0w1vr","pdf",342357,"English","# Introduction\n# Current Practice in UAE Hospitals\n# WHO Recommended Diagnostic Pathway\n# Materials and Methods\n# Results\n# Conclusion","[{\"question\":\"What diagnostic pathways does the study compare for suspected pulmonary MTB in Abu Dhabi?\",\"answer\":\"It compares the current hospital process using 3 AFB smears and MTB cultures for inpatient evaluation versus implementing the WHO X-pert MTB/RIF outpatient clinical pathway.\"},{\"question\":\"How was the study performed and what data were reported?\",\"answer\":\"A quality improvement project used a retrospective audit and data analysis of suspected pulmonary MTB admissions, reporting true accrued costs for current practice and estimated costs using the WHO pathway.\"},{\"question\":\"What were the main findings regarding cost and admissions?\",\"answer\":\"Cost analysis showed that 62% of diagnostic work-up costs were accumulated during admissions that ultimately proved MTB negative, and the WHO X-pert MTB/RIF pathway was estimated to cost about one-tenth as much as the current practice.\"}]","Cost Evaluation of Current Pulmonary MTB Diagnosis Process in a Hospital in Abu Dhabi - Proposal to Implement the World Health Organization MTB Clinical Pathway | PDF",1791220701,15]